vs
INTERPARFUMS INC（IPAR）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
INTERPARFUMS INC的季度营收约是REPLIGEN CORP的2.0倍（$386.2M vs $197.9M），INTERPARFUMS INC净利率更高（7.3% vs 6.7%，领先0.6%），REPLIGEN CORP同比增速更快（13.6% vs 6.8%），INTERPARFUMS INC自由现金流更多（$145.0M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 9.2%）
Inter Parfums Inc是全球知名的高端香水企业，开发、生产并销售多款授权香水、身体护理及相关美妆产品，与多家顶级奢侈时尚生活方式品牌合作推出联名香氛系列，产品覆盖全球主要市场，通过百货、美妆专营店及官方电商渠道触达消费者。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
IPAR vs RGEN — 直观对比
营收规模更大
IPAR
是对方的2.0倍
$197.9M
营收增速更快
RGEN
高出6.8%
6.8%
净利率更高
IPAR
高出0.6%
6.7%
自由现金流更多
IPAR
多$127.4M
$17.6M
两年增速更快
RGEN
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.2M | $197.9M |
| 净利润 | $28.1M | $13.3M |
| 毛利率 | 61.5% | 52.5% |
| 营业利润率 | 7.1% | 9.0% |
| 净利率 | 7.3% | 6.7% |
| 营收同比 | 6.8% | 13.6% |
| 净利润同比 | 16.0% | 143.9% |
| 每股收益（稀释后） | $0.88 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IPARRGEN
| Q4 25 | $386.2M | $197.9M | ||
| Q3 25 | $429.6M | $188.8M | ||
| Q2 25 | $333.9M | $182.4M | ||
| Q1 25 | $338.8M | $169.2M | ||
| Q4 24 | $361.5M | $174.1M | ||
| Q3 24 | $424.6M | $154.9M | ||
| Q2 24 | $342.2M | $154.1M | ||
| Q1 24 | $324.0M | $151.3M |
净利润IPARRGEN
| Q4 25 | $28.1M | $13.3M | ||
| Q3 25 | $65.8M | $14.9M | ||
| Q2 25 | $32.0M | $14.9M | ||
| Q1 25 | $42.5M | $5.8M | ||
| Q4 24 | $24.2M | $-30.3M | ||
| Q3 24 | $62.3M | $-654.0K | ||
| Q2 24 | $36.8M | $3.3M | ||
| Q1 24 | $41.0M | $2.1M |
毛利率IPARRGEN
| Q4 25 | 61.5% | 52.5% | ||
| Q3 25 | 63.5% | 53.2% | ||
| Q2 25 | 66.2% | 50.0% | ||
| Q1 25 | 63.7% | 53.6% | ||
| Q4 24 | 64.5% | 26.1% | ||
| Q3 24 | 63.9% | 50.0% | ||
| Q2 24 | 64.5% | 49.8% | ||
| Q1 24 | 62.5% | 49.5% |
营业利润率IPARRGEN
| Q4 25 | 7.1% | 9.0% | ||
| Q3 25 | 25.3% | 8.9% | ||
| Q2 25 | 17.7% | 7.6% | ||
| Q1 25 | 22.2% | 3.9% | ||
| Q4 24 | 10.0% | -17.7% | ||
| Q3 24 | 25.0% | -5.1% | ||
| Q2 24 | 18.9% | 1.0% | ||
| Q1 24 | 21.0% | 1.3% |
净利率IPARRGEN
| Q4 25 | 7.3% | 6.7% | ||
| Q3 25 | 15.3% | 7.9% | ||
| Q2 25 | 9.6% | 8.2% | ||
| Q1 25 | 12.5% | 3.4% | ||
| Q4 24 | 6.7% | -17.4% | ||
| Q3 24 | 14.7% | -0.4% | ||
| Q2 24 | 10.8% | 2.2% | ||
| Q1 24 | 12.7% | 1.4% |
每股收益（稀释后）IPARRGEN
| Q4 25 | $0.88 | $0.24 | ||
| Q3 25 | $2.05 | $0.26 | ||
| Q2 25 | $0.99 | $0.26 | ||
| Q1 25 | $1.32 | $0.10 | ||
| Q4 24 | $0.78 | $-0.55 | ||
| Q3 24 | $1.93 | $-0.01 | ||
| Q2 24 | $1.14 | $0.06 | ||
| Q1 24 | $1.27 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $137.1M | $767.6M |
| 总债务越低越好 | $176.0M | $542.2M |
| 股东权益账面价值 | $880.7M | $2.1B |
| 总资产 | $1.6B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.20× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资IPARRGEN
| Q4 25 | $137.1M | $767.6M | ||
| Q3 25 | $77.5M | $748.7M | ||
| Q2 25 | $53.9M | $708.9M | ||
| Q1 25 | $75.3M | $697.2M | ||
| Q4 24 | $109.3M | $757.4M | ||
| Q3 24 | $78.8M | $784.0M | ||
| Q2 24 | $37.7M | $809.1M | ||
| Q1 24 | $76.1M | $780.6M |
总债务IPARRGEN
| Q4 25 | $176.0M | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $157.3M | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IPARRGEN
| Q4 25 | $880.7M | $2.1B | ||
| Q3 25 | $870.9M | $2.1B | ||
| Q2 25 | $839.4M | $2.1B | ||
| Q1 25 | $788.6M | $2.0B | ||
| Q4 24 | $744.9M | $2.0B | ||
| Q3 24 | $778.5M | $2.0B | ||
| Q2 24 | $717.1M | $2.0B | ||
| Q1 24 | $708.1M | $2.0B |
总资产IPARRGEN
| Q4 25 | $1.6B | $2.9B | ||
| Q3 25 | $1.6B | $2.9B | ||
| Q2 25 | $1.6B | $2.9B | ||
| Q1 25 | $1.4B | $2.9B | ||
| Q4 24 | $1.4B | $2.8B | ||
| Q3 24 | $1.5B | $2.8B | ||
| Q2 24 | $1.4B | $2.9B | ||
| Q1 24 | $1.3B | $2.8B |
负债/权益比IPARRGEN
| Q4 25 | 0.20× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $146.5M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $145.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 37.5% | 8.9% |
| 资本支出强度资本支出/营收 | 0.4% | 4.1% |
| 现金转化率经营现金流/净利润 | 5.21× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $190.5M | $93.9M |
8季度趋势，按日历期对齐
经营现金流IPARRGEN
| Q4 25 | $146.5M | $25.7M | ||
| Q3 25 | $63.9M | $48.1M | ||
| Q2 25 | $11.9M | $28.6M | ||
| Q1 25 | $-7.4M | $15.0M | ||
| Q4 24 | $138.0M | $39.2M | ||
| Q3 24 | $76.1M | $49.3M | ||
| Q2 24 | $25.5M | $42.2M | ||
| Q1 24 | $-52.0M | $44.7M |
自由现金流IPARRGEN
| Q4 25 | $145.0M | $17.6M | ||
| Q3 25 | $57.6M | $43.4M | ||
| Q2 25 | $-3.3M | $21.5M | ||
| Q1 25 | $-8.8M | $11.4M | ||
| Q4 24 | $136.1M | $33.6M | ||
| Q3 24 | $75.4M | $42.3M | ||
| Q2 24 | $24.4M | $37.4M | ||
| Q1 24 | $-53.0M | $36.4M |
自由现金流率IPARRGEN
| Q4 25 | 37.5% | 8.9% | ||
| Q3 25 | 13.4% | 23.0% | ||
| Q2 25 | -1.0% | 11.8% | ||
| Q1 25 | -2.6% | 6.8% | ||
| Q4 24 | 37.7% | 19.3% | ||
| Q3 24 | 17.8% | 27.3% | ||
| Q2 24 | 7.1% | 24.3% | ||
| Q1 24 | -16.4% | 24.0% |
资本支出强度IPARRGEN
| Q4 25 | 0.4% | 4.1% | ||
| Q3 25 | 1.5% | 2.5% | ||
| Q2 25 | 4.5% | 3.9% | ||
| Q1 25 | 0.4% | 2.1% | ||
| Q4 24 | 0.5% | 3.2% | ||
| Q3 24 | 0.2% | 4.5% | ||
| Q2 24 | 0.3% | 3.1% | ||
| Q1 24 | 0.3% | 5.5% |
现金转化率IPARRGEN
| Q4 25 | 5.21× | 1.93× | ||
| Q3 25 | 0.97× | 3.23× | ||
| Q2 25 | 0.37× | 1.92× | ||
| Q1 25 | -0.17× | 2.57× | ||
| Q4 24 | 5.69× | — | ||
| Q3 24 | 1.22× | — | ||
| Q2 24 | 0.69× | 12.70× | ||
| Q1 24 | -1.27× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IPAR
| European Based Operations | $232.7M | 60% |
| United States Based Operations | $155.2M | 40% |
RGEN
暂无分部数据
